Updated Labeling for ACL Implant

January 22, 2026 1 min read Premium comments

Source: Miach Orthopaedics, Inc.

PremiumMiach Orthopaedicsknee osteoarthritisBEARGregory DiFelice

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for updated labeling of a resorbable implant for anterior cruciate ligament (ACL) repair, indicating a reduced risk of osteoarthritis.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: